Drug Profile
Research programme: atopic dermatitis therapeutics - Phytopharm
Alternative Names: P 55Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Phytopharm
- Class
- Mechanism of Action Interleukin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 07 Oct 2003 This programme is still in active development
- 29 Jan 2002 Preclinical development for Atopic dermatitis in United Kingdom (Topical)
- 03 May 1999 Phase-I clinical trials for Atopic dermatitis in United Kingdom (Topical)